Back to Journals » Cancer Management and Research » Volume 11

Beyond Ruxolitinib: Fedratinib and Other Emergent Treatment Options for Myelofibrosis

Total article views   HTML views PDF downloads Totals
13,801 Dovepress* 8,353+ 1,591 9,944
PubMed Central* 5,448 955 6,403
Totals 13,801 2,546 16,347
*Since 24 December 2019
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 2 3

View citations on PubMed Central and Google Scholar